Caxton Associates (New York)’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $495K | Sell |
1,402
-3,284
| -70% | -$1.16M | 0.02% | 330 |
|
|
2024
Q3 | $1.68M | Sell |
4,686
-4,666
| -50% | -$1.67M | 0.06% | 156 |
|
|
2024
Q2 | $2.98M | Buy |
+9,352
| New | +$2.98M | 0.1% | 101 |
|
|
2024
Q1 | – | Sell |
-30,000
| Closed | -$6.6M | – | 588 |
|
|
2023
Q4 | $6.6M | Buy |
30,000
+29,059
| +3,088% | +$6.39M | 0.34% | 57 |
|
|
2023
Q3 | $213K | Buy |
+941
| New | +$213K | 0.03% | 351 |
|
|
2020
Q3 | – | Sell |
-7,013
| Closed | -$849K | – | 506 |
|
|
2020
Q2 | $849K | Buy |
+7,013
| New | +$849K | 0.07% | 62 |
|
|
2020
Q1 | – | Sell |
-4,541
| Closed | -$400K | – | 588 |
|
|
2019
Q4 | $400K | Sell |
4,541
-2,099
| -32% | -$185K | 0.05% | 212 |
|
|
2019
Q3 | $530K | Buy |
+6,640
| New | +$530K | 0.11% | 112 |
|
|
2017
Q3 | – | Sell |
-2,800
| Closed | -$363K | – | 571 |
|
|
2017
Q2 | $363K | Buy |
2,800
+600
| +27% | +$77.8K | 0.01% | 365 |
|
|
2017
Q1 | $298K | Buy |
+2,200
| New | +$298K | ﹤0.01% | 297 |
|